Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib

類似資料

• Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma
  著者:: Anke E. M. van Erp, 等
  出版事項: (2022-01-01)
• Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo
  著者:: van Erp, Anke E. M., 等
  出版事項: (2020)
• The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
  著者:: Fleuren, Emmy D.G., 等
  出版事項: (2014)
• Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
  著者:: Subbiah, V., 等
  出版事項: (2021)
• PARP inhibition in UV-associated angiosarcoma preclinical models
  著者:: Weidema, Marije E., 等
  出版事項: (2021)